![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1437, 2004-01, pp. : 16-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Lipid-lowering therapy in diabetes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 342, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
National guidelines for lipid-lowering therapy unsatisfactory
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 348, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Colesevelam valuable adjunct in lipid-lowering therapy
Inpharma, Vol. 1, Iss. 1285, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Consider lipid-lowering therapy for patients with diabetes and hyperlipidaemia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Lipid-lowering therapy in acute coronary syndromes
Inpharma, Vol. 1, Iss. 1283, 2001-01 ,pp. :